What percent of ASCUS is cancer?

What percent of ASCUS is cancer?

Without prompt treatment or close monitoring, about 0.25 percent of women with atypical squamous cells of undetermined significance (ASCUS) develop cervical cancer within two years.

What are the current guidelines for a Pap test?

Women who are 21 to 29 should have a Pap test alone every 3 years. HPV testing alone can be considered for women who are 25 to 29, but Pap tests are preferred. Women who are 30 to 65 have three options for testing. They can have a Pap test and an HPV test (co-testing) every 5 years.

Should I worry about ASCUS?

Since the progression from severe deterioration of cervical cells to cancer generally takes about 5 to 10 years, the condition does not pose any immediate threat, please do not worry excessively.

Does ASCUS go away?

CONCLUSION: How to treat an ASCUS (Atypical Squamous Cells of Undetermined Significance) Pap test has been a major source of anxiety for patients and physicians. Most mild cervical abnormalities go away without treatment.

How do you treat ASCUS Pap?

If there are moderate to severe changes in your cervix, your doctor may want to remove the cervical tissue. Typically, your doctor will use the Loop Electrosurgical Excision Procedure (LEEP), or perform a cold knife cone biopsy as a minor surgical procedure.

When should I repeat Pap if ASCUS and negative HPV?

Repeat testing—For patients under 25, a repeat Pap test may be done in 6 months or 1 year. For patients 25 or older, repeat HPV testing or co-testing (having the HPV test and Pap test done at the same time) is recommended as a follow-up to some abnormal test results.

Which is worse LSIL or ASCUS?

ASCUS (Atypical squamous cells of undetermined significance). This means your Pap smear results are borderline, between normal and abnormal. This means your Pap smear results are borderline but may be more serious. LSIL (Low grade squamous intraepithelial lesion).

Can ASCUS be CIN3?

Normal repeat cytology results had an absolute risk of developing CIN3 of 3.1 percent; with a result of ASCUS, the risk was 7.9 percent; with LSIL, the risk was 9.2 percent; and with HSIL, the risk was significantly elevated at 42 percent.